WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia
2019 · Cancer Cell International · 33 citations
https://doi.org/10.1186/s12935-019-0773-6
H
Haiyan Cai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
913
Citations
15
h-index
18
i10-index
Haiyan Cai is an academic researcher from Panyu Hospital of Chinese Medicine. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Lymphocytic Leukemia Research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 15, co-authored 57 publications.
ORCID: 0000-0002-0280-4331Papers by this author
worksStructure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody
2020 · Cell Discovery · 12 citations
https://doi.org/10.1038/s41421-020-00202-9
Heparin Binds Lamprey Angiotensinogen and Promotes Thrombin Inhibition through a Template Mechanism
2016 · Journal of Biological Chemistry · 9 citations
https://doi.org/10.1074/jbc.m116.725895
ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway
2021 · Chemico-Biological Interactions · 4 citations
https://doi.org/10.1016/j.cbi.2021.109770
Supplementary Data from Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25124654.v1
Supplementary Table S4 from Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25124642
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat